Noticias de ARDX_US
Noticias del mercado
Últimas noticias sobre ARDX_US — 546 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common
DJS Law Group recuerda a los inversores una demanda colectiva contra Ardelyx, Inc. ("Ardelyx" o "la Compañía") (NASDAQ: ARDX) por violaciones de los artículos 10(b) y 20(a) de la Ley de Bolsa de Valores de 1934 y la Regla 10b-5 promulgada en virtud de la misma por la Comisión de Bolsa y Valores de Estados Unidos.
Ardelyx (NASDAQ:ARDX) expects to generate close to $500 million in revenue this year and reach profitability in 2027, supported by continued growth of its IBS-C treatment IBSRELA and hyperphosphatemia treatment XPHOZAH, executives said at a Morgan Stanley event. Chief Executive Officer Mike Raab sa
Ardelyx has seen its share price swing sharply in recent years, and the latest pullback puts the focus squarely on what investors are paying for the company’s current sales base. With sentiment shifting after a strong multi year move, the question now is how well the stock price lines up with the revenue it is already generating. Over the past 5 years Ardelyx has delivered a gain of 161.1%, which puts a lot of past optimism on the line when you ask whether the present valuation can still be...
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc. (“Ardelyx” or “the Company”) (NASDAQ: ARDX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Faruqi & Faruqi, LLP, una firma legal de valores líder a nivel nacional, está investigando posibles reclamos contra Ardelyx, Inc. (“Ardelyx” o la “Compañía”) (NASDAQ: ARDX) y recuerda a los inversionistas la fecha límite del 16 de noviembre de 2026 para buscar el papel de demandante principal en una demanda colectiva de valores federales que se ha presentado contra la Compañía.
Ardelyx has seen its share price swing sharply in recent years, and the latest pullback puts the focus squarely on what investors are paying for the company’s current sales base. With sentiment shifting after a strong multi year move, the question now is how well the stock price lines up with the revenue it is already generating. Over the past 5 years Ardelyx has delivered a gain of 161.1%, which puts a lot of past optimism on the line when you ask whether the present valuation can still be...
NEW YORK--(BUSINESS WIRE)--Sep 19, 2026--Faruqi & Faruqi, LLP, a leading national securities law fir
Página 14 de 28